Four things to know:
1. Senza Omnia delivers Nevro’s HF10 therapy as well as other spinal cord stimulation frequencies.
2. The device is equipped with a programmer that facilitates more waveforms across the spinal cord frequency spectrum.
3. Senza Omnia also features a redesigned patient remote that aims to improve the patient experience.
4. Nevro achieved FDA clearance for the SCS system in November.
More articles on devices:
Michigan providers sue governor over emergency declaration, aim to resume orthopedic surgery
4 recent innovations developed by spine surgeons
Dr. Kirk Campbell: How NYU Langone polished the virtual visit + why ‘patients will demand continued access’
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
